Filter
926
Text search:
Strengthening
Pharmaceutical
Systems
Featured
Recommendations
69
New Publications
277
Language
Document type
No document type
497
Studies & Reports
196
Guidelines
109
Strategic & Response Plan
59
Manuals
32
Fact sheets
14
Training Material
11
Situation Updates
4
Brochures
2
Resource Platforms
1
Infographics
1
Countries / Regions
Global
45
Kenya
44
Ethiopia
40
India
31
Sierra Leone
25
South Africa
25
Uganda
24
Liberia
23
Western and Central Europe
23
Nigeria
22
Rwanda
22
Tanzania
18
Zambia
17
Nepal
16
Malawi
15
Namibia
13
Africa
13
Bangladesh
12
Ukraine
12
Eastern Europe
12
Ghana
11
Lesotho
11
Syria
10
Zimbabwe
9
South–East Asia Region
9
Latin America and the Carribbean
9
Philippines
7
Cambodia
7
Indonesia
6
Eswatini/ Swaziland
6
Myanmar / Burma
6
West and Central Africa
6
Congo, Democratic Republic of
5
Thailand
5
Botswana
5
Asia
5
Guinea
4
Burkina Faso
4
Senegal
4
Haiti
4
East and Southern Africa
4
Cameroon
3
Pakistan
3
Jordan
3
Afghanistan
3
Mozambique
3
Eastern Europe and Central Asia
3
Albania
3
Laos
3
USA
2
South Sudan
2
China
2
Sudan
2
Benin
2
North Macedonia
2
Middle East and North Africa
2
Western Pacific Region
2
Lithuania
2
Vietnam
2
North America
2
Mali
1
Niger
1
Somalia
1
Iraq
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Brazil
1
El Salvador
1
Sri Lanka
1
Fiji
1
Venezuela
1
Southern Africa
1
Timor Leste/ East Timor
1
Russia
1
Bulgaria
1
Romania
1
Moldova
1
Iran
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
418
Public Health
54
Clinical Guidelines
41
Key Resources
33
Women & Child Health
16
Pharmacy & Technologies
12
Capacity Building
5
Toolboxes
AMR
113
COVID-19
67
Pharmacy
57
TB
47
HIV
45
Mental Health
35
Rapid Response
27
Global Health Education
23
NTDs
21
Planetary Health
20
Health Financing Toolbox
20
NCDs
19
Conflict
18
Caregiver
17
Ebola
12
Disability
6
Polio
5
Natural Hazards
5
Refugee
5
Specific Hazards
4
Health Financing
2
Cholera
1
Zika
1
Social Ethics
1
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f
...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-
...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e
...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол
...
The military offensive by the Russian Federation in Ukraine which began February 2022 has triggered one of the world’s fastest-growing displacement and humanitarian crisis, with geopolitical and economic ripples felt across the globe. The ongoing war has caused large-scale disruptions to the deliv
...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
This report analyses the intersection of HIV, COVID-19 and public debt in developing countries. The collision between COVID-19 and a crippling debt crisis have reversed decades of progress - putting present and future investments in health and HIV at risk. Pragmatic options to address the pandemic t
...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande
...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen
...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome
...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors.
...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that
...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy
...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de
...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
